Transgene SA (FRA:TGNA) (Q2 2024) Earnings Call Transcript Highlights: Promising Clinical Data ...

By Yahoo! Finance | Sep 25, 2024 at 01:06 PM EST

The CEO discusses data from BT-001 and TG4050 trials, R&D spending, FDA feedback, financial transactions, TG4001 program progress, oncolytic viruses platform, executive team additions, and future steps for TG4050. More details available in the full earnings call transcript.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.